Marrone Bio Innovations’ Majestene Bionematicide Awarded Best New Biopesticide in 2016 Agrow Awards
September 22 2016 - 8:30AM
Business Wire
Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading
global provider of bio-based pest management and plant health
products, announced today that its Majestene® Bionematicide product
has won the Biopesticide category in the 2016 Agrow Awards held in
London yesterday.
The prestigious Agrow Awards
(https://agrowawards.com/award-winners/), presented by Agrow, a
leading information provider for the global crop protection
industry, features 14 categories in areas such as R&D,
formulation, innovation, collaboration, marketing, business
strategy and corporate responsibility. Winners are judged by an
independent panel of industry experts. To be eligible for the
awards, products were required to be formulated in a way that is
acceptable to users and distributors, while also providing the
ability to forge a path in a market dominated by synthetic
chemicals.
“We are pleased and honored to have Majestene awarded Best New
Biopesticide,” said Pam Marrone, CEO of MBI. “With MBI products
Regalia and Grandevo being previous Agrow Award winners in the Best
New Biopesticide category, this recognition of a third MBI product
is a true testament to our success in bringing new agricultural
innovations to market that help growers protect and improve their
crop production. On behalf of everyone at MBI, I would like to
thank the Agrow Awards team for their recognition and for their
continued support in advancing awareness about biopesticides and
their important role in agriculture.”
Tony Torres, Product Marketing Manager, Insecticides &
Nematicides, added, “Receiving this award allows us to further
demonstrate that Majestene provides value in the fight against
nematodes, which are reported to cause $80 billion annually in
global damage to crops. Farmers now have a unique tool to suppress
nematodes and protect yield in a wide variety of crops, including:
potatoes, strawberries, tomatoes, cotton, corn, soybeans and
outside the US, bananas.”
Majestene, which was launched earlier in 2016, is labeled for a
wide array of crops against multiple nematodes such as root knot,
cyst, sting, burrowing and lance and is approved for use in
conventional and organic systems. It is available in a liquid
formulation and can be applied by ground, with no limit on the
number of applications allowed per season. Majestene has the
minimum four-hour re-entry interval for farmworkers. The product is
non-toxic to fish, birds and most beneficial insects, and also has
the advantages of a zero-day pre-harvest interval (PHI) and an
exemption from MRL (maximum residue level) tolerances — a measure
of pesticide residue limits that must be met for most food crop
exports.
About Marrone Bio Innovations
Smart. Natural. Solutions.
Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the
movement to a more sustainable world through the discovery,
development and promotion of biological products for pest
management and plant health. Our effective and environmentally
responsible solutions help customers operate more sustainably while
controlling pests, improving plant health, and increasing crop
yields. We have four products for agriculture on the market
(Regalia®, Grandevo®, Venerate® and Majestene®), and also
distribute Bio-tam 2.0® for Isagro USA in the western U.S. MBI also
markets Zequanox® for invasive mussels for water markets. We also
have a proprietary discovery process, a rapid development platform,
and a robust pipeline of pest management and plant health product
candidates. At Marrone Bio Innovations we are dedicated to
pioneering better biopesticides that support a better tomorrow for
users around the globe. For more information, please visit
www.marronebio.com.
Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that
involve substantial risks and uncertainties. All statements, other
than statements of historical facts, included in this press release
regarding strategy, future operations and plans, including
assumptions underlying such statements, are forward-looking
statements, and should not be relied upon as representing MBI’s
views as of any subsequent date. Examples of such statements
include statements regarding the potential of and market for MBI’s
Majestene product and its use and value to growers. Such
forward-looking statements are based on information available to
the Company as of the date of this release and involve a number of
risks and uncertainties, some beyond the Company's control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including risks
associated with marketing Majestene with MBI’s principal customers,
competition in the market for pest management products, lack of
understanding of bio-based pest management products by customers
and growers, adverse decisions by regulatory agencies and other
relevant third parties and the impact of weather conditions and
other factors affecting use of crop protection products .
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is under
no obligation to, and expressly disclaims any responsibility to,
update or alter forward-looking statements contained in this
release, whether as a result of new information, future events or
otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160922005605/en/
Marrone Bio Innovations:Nancy M. Hood, 530-302-8290VP
Marketingnhood@marronebio.comorMBI Investor:ICRJames
Palczynski, 203-682-8229James.Palczynski@icrinc.com
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Sep 2023 to Sep 2024